Dr. Alan Anderson

Equibles does not estimate personal net worth.

Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get AGIO alerts

About Dr. Alan Anderson

Dr. Alan Anderson has spoken on 1 investor event across 1 company, most recently for Agios Pharmaceuticals, Inc. on June 13, 2026. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), David P. Schenkein (Chairman) and 7 others.

Dr. Alan Anderson on recent calls

“I'm lucky to have the perspective of seeing patients across across the age continuum.”

Other, Agios Investor Event at EHA 2026 (Virtual) · June 13, 2026

Affiliation history

Agios Pharmaceuticals, Inc. (AGIO)
Transcript header (unverified)

Current

Company network

Agios Pharmaceuticals, Inc.

AGIO

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-06-13

View calls and events

Leadership on record at Agios Pharmaceuticals, Inc.

Brian Goff CEO, Board Member
Jacqualyn Fouse CEO, Board Member
David P. Schenkein Chairman
Jacqualyn A. Fouse Chairman
Cecilia Jones CFO
T.J. Washburn Chief Accounting Officer
Catherine Owen Adams Board Member
Cynthia Smith Board Member
David Scadden Board Member
David Scadden, M.D. Board Member

Recent activity

Investor Update Agios Investor Event at EHA 2026 (Virtual) Agios Pharmaceuticals, Inc. (AGIO)
2026-06-13